OneDigital Investment Advisors LLC lowered its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 17.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 446,315 shares of the company's stock after selling 93,535 shares during the quarter. OneDigital Investment Advisors LLC owned approximately 0.37% of Privia Health Group worth $8,725,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the stock. Quadrant Capital Group LLC grew its stake in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company's stock worth $95,000 after acquiring an additional 511 shares during the period. Park Avenue Securities LLC lifted its holdings in Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock valued at $287,000 after purchasing an additional 532 shares during the last quarter. PNC Financial Services Group Inc. boosted its position in Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock worth $140,000 after purchasing an additional 533 shares during the period. First Horizon Advisors Inc. increased its stake in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after purchasing an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. raised its position in shares of Privia Health Group by 6.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company's stock valued at $209,000 after purchasing an additional 678 shares during the period. Hedge funds and other institutional investors own 94.48% of the company's stock.
Privia Health Group Trading Down 1.2 %
Shares of Privia Health Group stock traded down $0.29 on Friday, hitting $23.17. 383,161 shares of the company traded hands, compared to its average volume of 775,303. The company has a market cap of $2.81 billion, a P/E ratio of 231.72, a P/E/G ratio of 3.47 and a beta of 0.88. The firm's 50-day simple moving average is $23.68 and its 200 day simple moving average is $21.82. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the stock. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. Canaccord Genuity Group lifted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Needham & Company LLC reissued a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a report on Thursday, April 10th. Robert W. Baird lifted their target price on Privia Health Group from $24.00 to $26.00 and gave the company an "outperform" rating in a report on Tuesday, April 15th. Finally, Truist Financial upped their price target on Privia Health Group from $27.00 to $28.00 and gave the company a "buy" rating in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $27.14.
Read Our Latest Report on PRVA
Insider Buying and Selling
In other news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares of the company's stock, valued at approximately $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 10.70% of the stock is owned by corporate insiders.
Privia Health Group Company Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
